Sandra Aliberti Selected Research

Immunotherapy

1/2023

Targeting cyclin-dependent kinases in sarcoma treatment: Current perspectives and future directions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sandra Aliberti Research Topics

Disease

4	Neoplasms (Cancer) 01/2023 - 05/2006
4	Sarcoma (Soft Tissue Sarcoma) 01/2023 - 01/2013
3	Neoplasm Metastasis (Metastasis) 09/2022 - 01/2013
3	Leiomyosarcoma 01/2020 - 01/2013
2	Leiomyoma (Uterine Fibroids) 09/2022 - 01/2020
1	Disease Progression 01/2020
1	Pain (Aches) 12/2019
1	Neutropenia 10/2018
1	Thrombocytopenia (Thrombopenia) 10/2018
1	Lymphopenia (Lymphocytopenia) 10/2018
1	Osteosarcoma (Osteogenic Sarcoma) 01/2017
1	Renal Insufficiency (Renal Failure) 01/2013
1	Ovarian Neoplasms (Ovarian Cancer) 01/2013
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 12/2009
1	Autoimmune Hepatitis 12/2009
1	Hepatitis 12/2009

Drug/Important Bio-Agent (IBA)

3	TrabectedinIBA 10/2018 - 01/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 01/2013
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2023
1	eribulin FDA Link 01/2020
1	olaparibIBA 10/2018
1	Alanine Transaminase (SGPT)IBA 10/2018
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2018
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	liposomal doxorubicin (Doxil)FDA Link 01/2013
1	Gemcitabine FDA Link 01/2013
1	Alkylating AgentsIBA 01/2013
1	DNA (Deoxyribonucleic Acid)IBA 01/2013
1	Ifosfamide FDA LinkGeneric 01/2013
1	PlatinumIBA 01/2013
1	AnthracyclinesIBA 01/2013
1	1-dodecylpyridoxal (PLD)IBA 01/2013
1	Imatinib Mesylate (Gleevec)FDA Link 12/2009

Therapy/Procedure

6	Therapeutics 01/2023 - 05/2006
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2013
1	Immunotherapy 01/2023
1	Morcellation 09/2022
1	Hysterectomy 01/2020
1	Activities of Daily Living (ADL) 12/2019